The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Update - June 2022

3 Aug 2022 07:00

RNS Number : 6687U
Honeycomb Investment Trust PLC
03 August 2022
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

03 August 2022

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company" or "Honeycomb") announces that the Investment Manager's monthly factsheet for 30 June 2022 is now available on its website at http://www.honeycombplc.com.

Net Asset Value per Share

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 30 June 2022 on a cum-income basis was 1,019.7 pence, based on a NAV of £354.2 million, and on an ex-income basis was 1,019.3 pence, based on a NAV of £354.1 million. The NAVs have been calculated by Apex Fund Services (UK) Ltd.

Honeycomb delivered a NAV return of 0.69% for the month, which is equivalent to 8.4% per annum. NAV return was driven by strong risk adjusted yield of 9.2%. Net Investment Assets remained broadly stable in the month at £583m with cash received from the recent Oplo Mortgage Portfolio sale being re-invested.

Pollen Street Credit had another active quarter for deployment completing a number of new transactions and facility upsizes. These include a £65m senior facility to Ark, a Swedish lender focused on providing financing to European technology businesses with each loan benefiting from a 70% principal guarantee from the European Infrastructure Fund; a £65m senior facility to TIER, the leading micro-mobility business in Europe; a £50m senior facility to Splend a vehicle leasing and financing business focused on the ridesharing and delivery driver markets in the UK and Australia; a €50m facility to Earlsfort, a residential development finance lender in Ireland; and we upsized our senior facility to iwoca by £25m, financing their UK SME portfolio. Honeycomb participated in a number of these transactions.

The pipeline of new opportunities is strong with over £400m of transactions in documentation or late stage DD across a range of end subsectors including insurance run off, SME asset backed and probate finance. The broader European pipeline is standing at over £2bn and is well diversified across subsectors and asset classes.

The broader macro environment remains uncertain with a number of risks and concerns with the impact of inflation and higher interest rates the most immediate threat albeit offset somewhat by continuing high levels of employment and rising nominal wages. We are monitoring the performance of the underlying assets closely and we are still seeing very consistent and good performance. We are factoring in the impact of higher prices and interest rates when underwriting and structuring and are also seeing opportunities in sectors with low correlation to the macro. The uncertain environment is also presenting opportunities and we are taking the opportunity to increase returns on new transactions alongside continuing to ensure prudent LTVs such that our investments are able to withstand significant stresses without impairment.

At the General Meeting of the Company held on 1 June 2022, shareholders approved the Company's proposed combination with Pollen Street Capital Holdings Limited ("Pollen Street") (the "Combination"). The Company and Pollen Street are finalising the remaining conditions precedent to complete the Combination within the coming weeks. The key timing dependency for completion is the receipt of remaining change in control approvals from certain regulators with oversight of firms within the Pollen Street Group, and the funds it manages or advises. Pollen Street and the Company have filed all documentation requested by those regulators, and the Financial Conduct Authority and Prudential Regulation Authority approved the change in control on 1 August. The Company will update shareholders when the remaining approvals have been received and completion can proceed.

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Barclays Bank PLC - Joint Broker

Neal West / Dion Di Miceli / Chris Madderson / Stuart Muress: +44 (0) 20 7623 2323

Liberum Capital Limited - Joint Broker

Chris Clarke: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

hitcosec@linkgroup.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVZLLFBLVLEBBZ
Date   Source Headline
21st Aug 20177:00 amRNSNet Asset Value - July 2017
21st Aug 20177:00 amRNSMonthly Update - July 2017
18th Aug 20177:00 amRNSHolding(s) in Company - TR-1 Notification
21st Jul 20177:00 amRNSNet Asset Value - June 2017
21st Jul 20177:00 amRNSMonthly Update - June 2017
21st Jun 20177:00 amRNSNet Asset Value(s) - May 2017
21st Jun 20177:00 amRNSMonthly Update - May 2017
5th Jun 201712:48 pmRNSHolding(s) in Company - TR-1 Notification
2nd Jun 20172:15 pmRNSResult of Annual General Meeting
31st May 20174:00 pmRNSResults of Initial Placing
25th May 201712:15 pmRNSPublication of Prospectus and Placing
18th May 20177:00 amRNSNet Asset Value - 30 April 2017
18th May 20177:00 amRNSMonthly Update - April 2017
28th Apr 20175:00 pmRNSNotice of AGM
28th Apr 20175:00 pmRNSAGM and Financial Statement Notification
28th Apr 20177:30 amRNSDividend Declaration - Period to 31 March 2017
28th Apr 20177:00 amRNSAnnual Report and Financial Statements - Dec 2016
25th Apr 201711:23 amRNSMonthly Update - March 2017
25th Apr 20177:00 amRNSNet Asset Value - March 2017
21st Mar 20177:00 amRNSNet Asset Value - February 2017
21st Mar 20177:00 amRNSMonthly Update - February 2017
28th Feb 20179:30 amRNSTransfer of shareholding
28th Feb 20177:00 amRNSDividend Declaration - Period to 31 December 2016
21st Feb 20179:59 amRNSMonthly Update - January 2017
21st Feb 20179:58 amRNSNet Asset Value - January 2017
19th Jan 20172:49 pmRNSMonthly Update - December 2016
19th Jan 20172:12 pmRNSNet Asset Value - December 2016
21st Dec 20164:19 pmRNSMonthly Update - November 2016
20th Dec 20169:41 amRNSHolding(s) in Company - TR-1 Notification
20th Dec 20169:38 amRNSHolding(s) in Company - TR-1 Notification
19th Dec 201610:32 amRNSHolding(s) in Company - TR-1 Notification
16th Dec 20162:57 pmRNSPDMR Shareholding
14th Dec 20167:00 amRNSNet Asset Value - November 2016
12th Dec 20165:16 pmRNSIssue of Equity - Results of placing
9th Dec 201611:46 amRNSProposed Placing
1st Dec 201612:40 pmRNSPublication of a Supplementary Prospectus
18th Nov 20169:54 amRNSMonthly Update - October 2016
14th Nov 20162:55 pmRNSNet Asset Value(s) - October 2016
10th Nov 20165:20 pmRNSDividend Declaration-Period End 30 September 2016
25th Oct 201612:15 pmRNSNet Asset Value - Change to NAV calculation basis
14th Oct 20161:20 pmRNSNet Asset Value(s) - September 2016
30th Sep 20163:18 pmRNSMonthly Update - August 2016
14th Sep 20163:04 pmRNSNet Asset Value(s) - August 2016
30th Aug 20166:06 pmRNSHalf-year Report
26th Aug 20163:29 pmRNSHalf-year Report
26th Aug 20163:19 pmRNSDividend Declaration
25th Aug 20165:42 pmRNSMonthly Update - July 2016
12th Aug 20164:56 pmRNSNet Asset Value(s) - July 2016
15th Jul 20163:15 pmRNSNet Asset Value - June 2016 replacement of 3538E
15th Jul 20162:18 pmRNSPortfolio Update - June 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.